Medical Products of Human Origin, UDI and ICCBBA: Supply Chain’s Role

By AHRMM

Some Human Cellular Tissue Products (HCTP) are considered “devices” and will require their assigned Unique Device Identifiers (UDI) to be tracked within the patient’s Electronic Health Record (EHR) and shared across the healthcare spectrum. Supply chain should be having interdepartmental conversations to determine how they will handle these types of products and their UDIs.

Related Resources

Toolkits/Methodology
Antibiotic resistant bacteria are an increasing concern to health care professionals.
Podcasts
Lana Makhanik and Peter Fiorentino discuss discus why Beth Israel Deaconess Medical Center is breathing easier after they overhauled their inventor
On-Demand Educational Webinars
When purchasing is involved at the start of the capital equipment process, it can lead to better value outcomes and improved customer experience at…
On-Demand Educational Webinars
An integrated culture, best in class supply chain practices, and data-driven insights all maximize savings and make a difference in health care…
Podcasts
Brent Petty discusses what forces are currently affecting healthcare and the platform hospitals use for decision making criteria.
On-Demand Educational Webinars
Management of inventory turns, reducing waste due to product expiration, and reducing annual audit shortfalls are all possible thanks to the UDI…